FDA Warns Compounder Over Lack of Prescriptions, Adulterated Products

Drug Industry Daily
A A
A compounding operation in Texas has landed an FDA warning letter for compounding drugs without prescriptions and for sterility concerns.

To View This Article:

Login

Subscribe To Drug Industry Daily